speb/financial-data huggingface dataset:
PHX.TO income_statement (quarterly, 2025-06-30) — EBIT: 12682000.00
PHX.TO income_statement (quarterly, 2025-06-30) — EBITDA: 26159000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -606000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 10696000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 4724000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -12164000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -7651000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 7651000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -200000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 29115000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 18665000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 196939000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 24226000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 483000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 483000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -995000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 58213000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 263579000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -17882000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2171000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 15674000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 29188000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 41739000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 70927000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 15674000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -927000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 31043000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 343000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Income: 8522000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 8522000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 8522000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 8522000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 8522000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 8522000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 8522000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -1905000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -1186000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 14747000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 14747000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1186000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -911000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -6115000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 196939000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -9862000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 203175000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 556000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 18504000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 556000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 18504000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 18708000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 3316866.63
PHX.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 10489000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -7308000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Operating Income: 5934000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 167670000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 45453472.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 29115000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 7451000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 18665000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1186000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1366000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1249000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 196939000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Payables: 113591000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 113591000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 3875000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 12199000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 1373000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -1905000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -20748000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 137403000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 143444000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 13477000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -927000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Research And Development: 1607000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -17814000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 10886000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 16685000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 45456773.00
PHX.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 7651000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 151000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 221840000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 203175000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 2245866.63
PHX.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 3677000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
PHX.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1916000.00
PHX.TO cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -5252000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 429884000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 263579000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 74700000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 221840000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 161736000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 208044000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 219697000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 90680000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 703000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1233000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 7451000.00
PHX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 7451000.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 3301.00
PHX.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 92823000.00
PHX.TO income_statement (annual, 2025-12-31) — +Operating Expense: 71276000.00
PHX.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 17669000.00
PHX.TO income_statement (annual, 2025-12-31) — +Total Revenue: 709598000.00
PHX.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 183891000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 110896000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 110896000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 138640000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 138640000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -331293000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -331293000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7326000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7326000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -300000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -300000.00
PHX.TO income_statement (annual, 2025-12-31) — Average Dilution Earnings: -2750000.00
PHX.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 45214876.00
PHX.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 45048718.00
PHX.TO income_statement (annual, 2025-12-31) — Basic EPS: 1.21
PHX.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.39
PHX.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 14163000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 7871000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 20949000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 20949000.00
PHX.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -76992000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -9481000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 31443000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 31443000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 201722000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 201722000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 29107000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 29107000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 29107000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 29107000.00
PHX.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -36342000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -9036000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 29107000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 29107000.00
PHX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -23408000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -16288000.00
PHX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -34164000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 6314000.00
PHX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 73156000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 31681000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 6874000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 210000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -10252000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Payable: -6314000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -6314000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -342000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -5051000.00
PHX.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -14875000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4729000.00
PHX.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 15584000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 21707000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Common Stock: 201722000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 201722000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 229043000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 229043000.00
PHX.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 598634000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 155138000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Current Assets: 236268000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 236268000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 4050000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 4050000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4050000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4050000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 125358000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 125358000.00
PHX.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 10823000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 157000.00
PHX.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 10823000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 157000.00
PHX.TO cash_flow (annual, 2025-12-31) — Depreciation: 61777000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 17636000.00
PHX.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 61777000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 17636000.00
PHX.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 61777000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 17636000.00
PHX.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 48415929.00
PHX.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 50197143.00
PHX.TO income_statement (annual, 2025-12-31) — Diluted EPS: 1.13
PHX.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.35
PHX.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 51960000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 14817000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 9074000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 9074000.00
PHX.TO income_statement (annual, 2025-12-31) — EBIT: 67454000.00
PHX.TO income_statement (quarterly, 2025-12-31) — EBIT: 18185000.00
PHX.TO income_statement (annual, 2025-12-31) — EBITDA: 129231000.00
PHX.TO income_statement (quarterly, 2025-12-31) — EBITDA: 35821000.00
PHX.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -640000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -471000.00
PHX.TO cash_flow (annual, 2025-12-31) — End Cash Position: 29107000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 29107000.00
PHX.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -23408000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -16288000.00
PHX.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -3836000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 22200000.00
PHX.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -30383000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -8203000.00
PHX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 30383000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 8203000.00
PHX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -205000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -247000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 29889000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 29889000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 16304000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 16304000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 138940000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 138940000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 517705000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 517705000.00
PHX.TO income_statement (annual, 2025-12-31) — Gross Profit: 110964000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 28753000.00
PHX.TO income_statement (annual, 2025-12-31) — Interest Expense: 1921000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 461000.00
PHX.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1921000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 461000.00
PHX.TO cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -4386000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -1010000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Inventory: 56261000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 56261000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 264532000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 264532000.00
PHX.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -34164000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 6314000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 2171000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2171000.00
PHX.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 19021000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -7000000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 27393000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 27393000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 35489000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 35489000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 62882000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 62882000.00
PHX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 19021000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -7000000.00
PHX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -3700000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -935000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 54044000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 54044000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Net Debt: 6382000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 6382000.00
PHX.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 255000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 252000.00
PHX.TO income_statement (annual, 2025-12-31) — Net Income: 54710000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Income: 17567000.00
PHX.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 54710000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 17567000.00
PHX.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 54710000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 17567000.00
PHX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 54710000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 17567000.00
PHX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 54710000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 17567000.00
PHX.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 54710000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 17567000.00
PHX.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 54710000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 17567000.00
PHX.TO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -4699000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
PHX.TO income_statement (annual, 2025-12-31) — Net Interest Income: -4842000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -1207000.00
PHX.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 15321000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -7935000.00
PHX.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 15321000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -7935000.00
PHX.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4842000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1207000.00
PHX.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -3250000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
PHX.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 542000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 4441000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Net PPE: 186412000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 186412000.00
PHX.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -30007000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 1873000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 212739000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 212739000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 756000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 756000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 24317000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 24317000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 756000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 756000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 24317000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 24317000.00
PHX.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 99251000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 28063000.00
PHX.TO income_statement (annual, 2025-12-31) — Normalized Income: 29676700.00
PHX.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 9877720.72
PHX.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 73156000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 31681000.00
PHX.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -30128000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -7951000.00
PHX.TO income_statement (annual, 2025-12-31) — Operating Income: 39688000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Operating Income: 11084000.00
PHX.TO income_statement (annual, 2025-12-31) — Operating Revenue: 709598000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 183891000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 45367773.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 45367773.00
PHX.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 29889000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 29889000.00
PHX.TO income_statement (annual, 2025-12-31) — Other Income Expense: 30687000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 7847000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 16304000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 16304000.00
PHX.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 4842000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1207000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1253000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1253000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1564000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1564000.00
PHX.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 707000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 89000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Other Properties: 442712000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 442712000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Payables: 121308000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Payables: 121308000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 121308000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 121308000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2970000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2970000.00
PHX.TO income_statement (annual, 2025-12-31) — Pretax Income: 65533000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 17724000.00
PHX.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 863000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 683000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PHX.TO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 4095000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 1103000.00
PHX.TO cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -4699000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: 0.00
PHX.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -72293000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -9481000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 54701000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 54701000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Receivables: 147930000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 147930000.00
PHX.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 598634000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 155138000.00
PHX.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 61777000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 17636000.00
PHX.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3700000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -935000.00
PHX.TO income_statement (annual, 2025-12-31) — Research And Development: 6816000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Research And Development: 1685000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -9894000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -9894000.00
PHX.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 42286000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 11354000.00
PHX.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 64460000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 15984000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Share Issued: 45371074.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 45371074.00
PHX.TO income_statement (annual, 2025-12-31) — Special Income Charges: 30185000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 8005000.00
PHX.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 405000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 48000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 229043000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 229043000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 212739000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 212739000.00
PHX.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 4946700.00
PHX.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 68720.72
PHX.TO income_statement (annual, 2025-12-31) — Tax Provision: 10823000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 157000.00
PHX.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.17
PHX.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.01
PHX.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 9290000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 9290000.00
PHX.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -14107000.00
PHX.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -1805000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Assets: 443164000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 443164000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 264532000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 264532000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Debt: 66932000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 66932000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 229043000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 229043000.00
PHX.TO income_statement (annual, 2025-12-31) — Total Expenses: 669910000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 172807000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 214121000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 214121000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 206896000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 206896000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 88763000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 88763000.00
PHX.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 2921000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 746000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1338000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1338000.00
PHX.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 29980000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 7758000.00
PHX.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 29980000.00
PHX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 7758000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 3301.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 3301.00
PHX.TO balance_sheet (annual, 2025-12-31) — Work In Process: 1560000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 1560000.00
PHX.TO balance_sheet (annual, 2025-12-31) — Working Capital: 110910000.00
PHX.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 110910000.00
PHX.TO income_statement (annual, 2025-12-31) — Write Off: 198000.00
PHX.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 28017000.00
PHX.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 183885000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 118720000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 162763000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 7169000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: -117000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 44680000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.20
PHX.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 29107000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -29871000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 30579000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 202948000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 18993000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 18993000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -18148000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 18993000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 8477000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -18300000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -532000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -17243000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -10355000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 202948000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -18148000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 223721000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 153518000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 254203000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4127000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4127000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 132177000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 2067000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 2067000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 17785000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 17785000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 17785000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 44680000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.20
PHX.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 8936000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 9101000.00
PHX.TO income_statement (quarterly, 2026-03-31) — EBIT: 11446000.00
PHX.TO income_statement (quarterly, 2026-03-31) — EBITDA: 29231000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 241000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 18993000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 8477000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -30403000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -9359000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 9359000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 159000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 32737000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 16872000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 197008000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 30367000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 443000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 443000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -888000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 59269000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 286112000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -18300000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2171000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 26642000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 26452000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 62391000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 88843000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 26642000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -988000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 43398000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -90000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Income: 8936000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 8936000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 8936000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 8936000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 8936000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 8936000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 8936000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -1365000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -1161000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 25654000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 25654000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1161000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -714000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 197008000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -16221000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 206849000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1583000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 26377000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1583000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 26377000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 19596000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 1111010.45
PHX.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -532000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -9449000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Operating Income: 2350000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 183885000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 45499105.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 32737000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 9814000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 16872000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1161000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 981000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1700000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 179000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 197008000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Payables: 128050000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 128050000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2516000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 11003000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 971000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 610000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -1365000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -28506000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 173425000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 153518000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 17785000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -988000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Research And Development: 1883000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -19133000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 12285000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 26134000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 45502406.00
PHX.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: 9476000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 98000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 223721000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 206849000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1810010.45
PHX.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 2067000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
PHX.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 10662000.00
PHX.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -3492000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 472818000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 286112000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 92970000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 223721000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 181535000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 249097000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 218615000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 116920000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 718000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 229000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 9635000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 9635000.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 3301.00
PHX.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 122026000.00
PHX.TO income_statement (quarterly, 2026-03-31) — Write Off: -117000.00
PHYS.TO balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 5001081000.00
PHYS.TO cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: 0.00
PHYS.TO cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
PHYS.TO income_statement (annual, 2022-12-31) — +Operating Expense: 3540000.00
PHYS.TO income_statement (annual, 2022-12-31) — +Total Revenue: -78930000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 144000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 136000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 5745945000.00
PHYS.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 385920497.00
PHYS.TO income_statement (annual, 2022-12-31) — Basic EPS: -0.21
PHYS.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 6982000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 5252688000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 294000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 294000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 294000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (annual, 2022-12-31) — Change In Payable: 104000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 104000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -6688000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Common Stock: 5252688000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 5746095000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 822541000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -185000.00
PHYS.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 385920497.00
PHYS.TO income_statement (annual, 2022-12-31) — Diluted EPS: -0.21
PHYS.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -82470000.00
PHYS.TO cash_flow (annual, 2022-12-31) — End Cash Position: 294000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 5745945000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 820542000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -22684000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 59682000.00
PHYS.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 324000.00
PHYS.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 2347000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -804546000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 5745945000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 5745945000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 822541000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 822356000.00
PHYS.TO income_statement (annual, 2022-12-31) — Net Income: -82470000.00
PHYS.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -82470000.00
PHYS.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -82470000.00
PHYS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -82470000.00
PHYS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -82470000.00